The Evaluation of the Effectiveness and Safety of Nalbuphine Hydrochloride Injection for Analgesia in ICU Patients: A Multicenter, Randomized, Single-blinded, Parallel, Two-step Trial

Recruiting

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(1 site)

China

Wuhan Union Hospital, Wuhan, Hubei

Phase

Safety & dosing / Large-scale testing

Sponsor

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

Collaborators

Yichang Humanwell Pharmaceutical Co., Ltd., China

Enrollment target

~204 participants

Started

August 2023

Primary completion

October 2025

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

18 Years – 80 Years

Last updated January 2025